Holen Sie sich die Stockscreener-App
22.32
0.27%
0.06
Handel nachbörslich:
22.32
Acadia Pharmaceuticals Inc Aktie (ACAD) Neueste Nachrichten
Glioblastoma Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | InovioPharma, Pfizer, Roche, ACADIA Pharma, BioNTech, Oncotelic Therapeutics, Autotelic Therapeuti - Barchart
BofA Securities Lifts ACADIA Pharmaceuticals Inc. (ACAD)’s Price Target To $23, Maintains Neutral Rating - msn.com
Layoff Watch: Is ACADIA Pharmaceuticals Inc being accumulated by smart moneyStop Loss & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Update Recap: Can ACADIA Pharmaceuticals Inc continue delivering strong returns - baoquankhu1.vn
Acadia Pharmaceuticals stock drops 3.35% as company gears up for post-acute care conference - Traders Union
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Receives Consensus Rating of "Moderate Buy" from Brokerages - marketbeat.com
A Look At ACADIA Pharmaceuticals (ACAD) Valuation After Recent Mixed Share Performance - simplywall.st
Acadia Pharma EVP Schneyer sells $159k in stock By Investing.com - Investing.com Australia
Acadia Pharma EVP Schneyer sells $159k in stock - Investing.com UK
Acadia Pharmaceuticals exec sells $41,895 in stock By Investing.com - Investing.com India
Acadia Pharmaceuticals exec sells $41,895 in stock - Investing.com
Acadia EVP Thompson sells $73k in stock after option exercise - Investing.com
Acadia EVP Rhodes sells $82k in stock after option exercise - Investing.com
Acadia Pharma CEO Owen Adams Catherine sells $249k in stock - Investing.com
Acadia Pharma CEO Owen Adams Catherine sells $249k in stock By Investing.com - Investing.com India
Acadia EVP Rhodes sells $82k in stock after option exercise By Investing.com - Investing.com South Africa
ACADIA (NASDAQ: ACAD) officer sells 1,942 shares after RSU vesting - stocktitan.net
ACADIA Pharmaceuticals (NASDAQ: ACAD) — Vanguard reports 0 shares in amendment - stocktitan.net
Acadia Pharmaceuticals stock price forecast: overbought conditions persist as ACAD closes near key resistance - Traders Union
This General Motors Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga
ACADIA Pharmaceuticals Shares Rise After BofA Upgrade - Moomoo
Acadia Pharmaceuticals upgraded on improve risk-reward profile following pullback - Yahoo Finance
Acadia Pharmaceuticals (ACAD) Upgraded to Buy by BofA - GuruFocus
Acadia Pharma upgraded at BofA following stock pullback - msn.com
Acadia Pharmaceuticals upgraded to Buy at BofA following 25% pullback - TipRanks
ACAD: B of A Securities Upgrades ACADIA Pharmaceuticals Rating t - GuruFocus
ACADIA Pharmaceuticals (NASDAQ:ACAD) Raised to "Buy" at Bank of America - marketbeat.com
BofA upgrades Acadia Pharmaceuticals stock rating on valuation - Investing.com
RBC Capital Sticks to Their Buy Rating for ACADIA Pharmaceuticals (ACAD) - theglobeandmail.com
BofA upgrades Acadia Pharmaceuticals stock rating on valuation By Investing.com - Investing.com Canada
B of A Securities upgrades ACADIA Pharmaceuticals (ACAD) - msn.com
RBC Capital Maintains ACADIA Pharmaceuticals(ACAD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Hudson Bay Capital Management LP Sells 119,700 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Market Recap: How does ACADIA Pharmaceuticals Inc compare to its peersBreakout Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Hedge Fund Moves: How does ACADIA Pharmaceuticals Inc compare to its peersProfit Target & Long-Term Safe Investment Plans - baoquankhu1.vn
Aug Outlook: Does ACADIA Pharmaceuticals Inc offer margin of safety2026 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Acadia (NASDAQ: ACAD) director receives new option and RSU awards - Stock Titan
ACADIA (NASDAQ: ACAD) director Jonathan Poole submits initial Form 3 insider report - Stock Titan
ACAD Stock Down 10% Following Phase III Hyperphagia Study Failure - msn.com
Mizuho upgrades ACADIA Pharmaceuticals (ACAD) - MSN
Oppenheimer maintains a balanced outlook on ACADIA Pharmaceuticals Inc. (ACAD) for 2026 - MSN
Wolfe Research notes conviction-driven opportunities in ACADIA Pharmaceuticals Inc.’s (ACAD) therapeutic domains - MSN
ACADIA Pharmaceuticals invites engagement at major pediatric event - Traders Union
ACADIA Pharmaceuticals Inc. (ACAD) Latest Stock News & Headlines - Yahoo Finance
ACADIA Pharmaceuticals Maps Key CNS Readouts: Remlifanserin ADP Data Due Aug–Oct, ACP-211 Next Year - Yahoo Finance
ACADIA Pharmaceuticals at Stifel CNS Forum: Strategic Insights Unveiled - Investing.com India
ACADIA Pharmaceuticals at Stifel CNS Forum: Strategic Insights Unveiled By Investing.com - Investing.com Canada
Algert Global LLC Has $8.54 Million Stake in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
(ACAD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
ACADIA Pharmaceuticals (ACAD) Is Down 5.3% After EMA Rejects Trofinetide In Rett ReviewWhat's Changed - simplywall.st
Acadia Pharmaceuticals annual revenue surpasses 1 billion dollars at Nasdaq bell ceremony - Traders Union
Acadia Pharmaceuticals Rings the Opening Bell - Nasdaq
Acadia Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Fred Alger Management LLC Sells 820,421 Shares of ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
Assessing ACADIA Pharmaceuticals (ACAD) Valuation After Recent Share Price Weakness - Yahoo Finance
Braidwell LP Makes New $50.76 Million Investment in ACADIA Pharmaceuticals Inc. $ACAD - MarketBeat
ACADIA Pharmaceuticals confirms role at Stifel 2026 Virtual CNS Forum - Traders Union
Has ACADIA Pharmaceuticals (ACAD) Pullback Opened A New Opportunity For Investors? - simplywall.st
1.52%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):